Sam Hooshmand is a Neurology physician affiliated with Medical College of Wisconsin. OpenAlex indexes 22 publications with 217 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9200 W Wisconsin Ave
Milwaukee, WI 532263522
Telephone
414-805-5200Provider last certified this registry record 3 Jun 2020.
Industry payments
13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- TG Therapeutics, Inc.Program year202548 payments$68,218openpaymentsdata.cms.gov ↗
- EMD Serono, Inc.Program year202541 payments$58,803openpaymentsdata.cms.gov ↗
- Amgen Inc.Program year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
60.4%Gabapentinoids15.9%Gabapentin100%Part D≥30 patientsPotassium Channel Blocker8.9%Dalfampridine Er100%Part D≥19 patients+ 11 more classes in this area
Musculoskeletal
26%gamma-Aminobutyric Acid-ergic Agonist19.8%Baclofen100%Part D≥37 patientsCentral alpha-2 Adrenergic Agonist6.2%Tizanidine Hcl100%Part D≥14 patientsCancer & immunology
11%Pyrimidine Synthesis Inhibitor4.9%Teriflunomide100%Part D<11 patientsCD20-directed Cytolytic Antibody3.3%Kesimpta Pen100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Clinical Characterization and Long-Term Outcome in Children and Adults With Anti-AMPA Receptor Encephalitis
Neurology Neuroimmunology & Neuroinflammation
2025 - Clinical decision support improves autoimmune/paraneoplastic antibody panel utilization
American Journal of Clinical Pathology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Razelle Kurzrock, MD
Medical College of Wisconsin
Mary Horowitz, MD
Medical College of Wisconsin
Janet Rader, MD
Medical College of Wisconsin
Bruce Camitta, MD
Medical College of Wisconsin
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”